Honeywell Conference Appearance Adds No New Information; Thesis Unchanged

What happened

Honeywell presented at the Wolfe Research conference, reiterating its Q3 2026 aerospace separation timeline and overall strategy. The presentation contained no material new disclosures beyond what was already in the deep value report. The stock closed at $235, within the WAIT range, and the key catalysts remain the June 3 Aerospace Investor Day and Form 10 progress. With no delta from the event, the investment thesis stands: wait for better price or better information on standalone margins and normalized free cash flow.

Implication

Keep position sizing conservative until the June 3 Investor Day provides clarity on Aerospace standalone margins and capital structure. A pullback toward $220 would improve risk/reward.

Thesis delta

There is no thesis delta. The conference appearance confirmed existing expectations without altering the risk-reward calculus. The next 3-6 months hinge on the Investor Day and Form 10 effectiveness; until then, the WAIT rating remains appropriate.